{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,12]],"date-time":"2026-09-12T20:27:26Z","timestamp":1789244846465,"version":"build-2803163510"},"reference-count":10,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2021,1,1]],"date-time":"2021-01-01T00:00:00Z","timestamp":1609459200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,1,1]],"date-time":"2021-01-01T00:00:00Z","timestamp":1609459200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","journal-of-hepatology.eu","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Hepatology"],"published-print":{"date-parts":[[2021,1]]},"DOI":"10.1016\/j.jhep.2020.08.024","type":"journal-article","created":{"date-parts":[[2020,10,15]],"date-time":"2020-10-15T03:45:59Z","timestamp":1602733559000},"page":"254-255","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":3,"title":["A spotlight on natural killer cells in primary biliary cholangitis"],"prefix":"10.1016","volume":"74","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-7768-6886","authenticated-orcid":false,"given":"Theresa","family":"Hydes","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Salim I.","family":"Khakoo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jhep.2020.08.024_bib1","doi-asserted-by":"crossref","first-page":"965","DOI":"10.1016\/j.jhep.2020.05.041","article-title":"Primary biliary cholangitis: a multifaceted pathogenesis with potential therapeutic targets","volume":"73","author":"Carbone","year":"2020","journal-title":"J\u00a0Hepatol"},{"key":"10.1016\/j.jhep.2020.08.024_bib2","doi-asserted-by":"crossref","first-page":"634","DOI":"10.1016\/j.immuni.2015.09.013","article-title":"Natural killer cell memory","volume":"43","author":"O'Sullivan","year":"2015","journal-title":"Immunity"},{"key":"10.1016\/j.jhep.2020.08.024_bib3","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1016\/j.cytogfr.2018.08.001","article-title":"Natural killer cells in inflammation and autoimmunity","volume":"42","author":"Zitti","year":"2018","journal-title":"Cytokine Growth Factor Rev"},{"key":"10.1016\/j.jhep.2020.08.024_bib4","first-page":"1106","article-title":"Blood and liver-infiltrating lymphocytes in primary biliary cirrhosis: increase in activated T and natural killer cells and recruitment of primed memory T cells","volume":"13","author":"Bj\u00f6rkland","year":"1991","journal-title":"Hepatology"},{"key":"10.1016\/j.jhep.2020.08.024_bib5","doi-asserted-by":"crossref","first-page":"232","DOI":"10.1016\/j.jaut.2006.04.001","article-title":"Increased killing activity and decreased cytokine production in NK cells in patients with primary biliary cirrhosis","volume":"26","author":"Chuang","year":"2006","journal-title":"J\u00a0Autoimmun"},{"key":"10.1016\/j.jhep.2020.08.024_bib6","doi-asserted-by":"crossref","first-page":"1270","DOI":"10.1002\/hep.24194","article-title":"Interaction between Toll-like receptors and natural killer cells in the destruction of bile ducts in primary biliary cirrhosis","volume":"53","author":"Shimoda","year":"2011","journal-title":"Hepatology"},{"key":"10.1016\/j.jhep.2020.08.024_bib7","doi-asserted-by":"crossref","first-page":"1944","DOI":"10.1002\/hep.26979","article-title":"IL-12\/Th1 and IL-23\/Th17 biliary microenvironment in primary biliary cirrhosis: implications for therapy","volume":"59","author":"Yang","year":"2014","journal-title":"Hepatology"},{"key":"10.1016\/j.jhep.2020.08.024_bib8","doi-asserted-by":"crossref","first-page":"1817","DOI":"10.1002\/hep.28122","article-title":"Natural killer cells regulate T cell immune responses in primary biliary cirrhosis","volume":"62","author":"Shimoda","year":"2015","journal-title":"Hepatology"},{"key":"10.1016\/j.jhep.2020.08.024_bib9","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3389\/fimmu.2019.02633","article-title":"Constitutive activation of natural killer cells in primary biliary cholangitis","volume":"10","author":"Hydes","year":"2019","journal-title":"Front Immunol"},{"key":"10.1016\/j.jhep.2020.08.024_bib10","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1002\/hep.28359","article-title":"Ustekinumab for patients with primary biliary cholangitis who have an inadequate response to ursodeoxycholic acid: a proof-of-concept study","volume":"64","author":"Hirschfield","year":"2016","journal-title":"Hepatology"}],"container-title":["Journal of Hepatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0168827820335959?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0168827820335959?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,29]],"date-time":"2025-09-29T19:40:45Z","timestamp":1759174845000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0168827820335959"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,1]]},"references-count":10,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2021,1]]}},"alternative-id":["S0168827820335959"],"URL":"https:\/\/doi.org\/10.1016\/j.jhep.2020.08.024","relation":{},"ISSN":["0168-8278"],"issn-type":[{"value":"0168-8278","type":"print"}],"subject":[],"published":{"date-parts":[[2021,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"A spotlight on natural killer cells in primary biliary cholangitis","name":"articletitle","label":"Article Title"},{"value":"Journal of Hepatology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jhep.2020.08.024","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"https:\/\/doi.org\/10.1016\/j.jhep.2020.05.041","name":"associatedlink","label":"CrossRef DOI link to the associated document"},{"value":"simple-article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 European Association for the Study of the Liver. Published by Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}